ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CRDN Ceradyne, Inc. (MM)

35.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Ceradyne, Inc. (MM) NASDAQ:CRDN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 35.00 0 01:00:00

Company News for June 16, 2011 - Corporate Summary

16/06/2011 10:10am

Zacks



•    Share prices of Scotts Miracle-Gro Company (NYSE:SMG) dipped 6.02% after the company reduced its earnings estimate for the fiscal year 2011

•    Shares of Owens-Illinois (NYSE:OI) dropped 13.54% to close at $25.54 after the company said its second quarter earnings figures could fall due to a jump in manufacturing and delivery expenses

•    Johnson & Johnson (NYSE:JNJ) is reportedly pulling out of the drug-coated heart stent market because of continually declining sales. The global market for this segment is valued at $4 billion

•    Analysts at Jefferies & Co. initiated coverage on shares of General Mills, Inc. (NYSE:GIS) with "Hold" rating and a target price of $40

•    Analysts at Jefferies & Co. initiated coverage on Shares of Kellogg (NYSE:K) with "Underperform" rating and also lowered the target price of the stock to $47

•    Analysts at Auriga downgraded Myriad Genetics (NASDAQ:MYGN) to "Hold" rating from "Buy" rating, cutting the target price to $25 from $27

•    Analysts at Wedbush downgraded shares of Ceradyne (NASDAQ:CRDN) to "Neutral" rating from "Outperform" rating

•    Analysts at Wedbush downgraded shares of AngioDynamics (NASDAQ:ANGO) to an "Underperform" rating

•    Wells Fargo upgraded Hospitality Properties Trust (NYSE:HPT) to "Outperform" rating from "Market Perform" rating

•    Pharma company AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) has priced its public offering of 5.75 million shares at $17.50 per share.  This offering is expected to bring in $100.6 million before expenses, which will be used for general corporate needs
 
ANGIODYNAMICS (ANGO): Free Stock Analysis Report
 
AVEO PHARMACEUT (AVEO): Free Stock Analysis Report
 
CERADYNE INC (CRDN): Free Stock Analysis Report
 
GENL MILLS (GIS): Free Stock Analysis Report
 
HOSPITALITY PRP (HPT): Free Stock Analysis Report
 
JOHNSON & JOHNS (JNJ): Free Stock Analysis Report
 
KELLOGG CO (K): Free Stock Analysis Report
 
MYRIAD GENETICS (MYGN): Free Stock Analysis Report
 
OWENS-ILLINOIS (OI): Free Stock Analysis Report
 
SCOTTS MIRCL-GR (SMG): Free Stock Analysis Report
 
Zacks Investment Research

1 Year Ceradyne, Inc. (MM) Chart

1 Year Ceradyne, Inc. (MM) Chart

1 Month Ceradyne, Inc. (MM) Chart

1 Month Ceradyne, Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock